Friday, July 4, 2025

Creating liberating content

Introducing deBridge Finance: Bridging...

In the dynamic landscape of decentralized finance (DeFi), innovation is a constant,...

Hyperliquid Airdrop: Everything You...

The Hyperliquid blockchain is redefining the crypto space with its lightning-fast Layer-1 technology,...

Unlock the Power of...

Join ArcInvest Today: Get $250 in Bitcoin and a 30% Deposit Bonus to...

Claim Your Hyperliquid Airdrop...

How to Claim Your Hyperliquid Airdrop: A Step-by-Step Guide to HYPE Tokens The Hyperliquid...
HomePoliticsInfarmed bans the...

Infarmed bans the export of 130 medicines

According to an information circular issued this Monday, the National Medicines Administration (Infarmed) has banned the export of 130 drugs of various categories and active substances, such as ibuprofen, insulin or paracetamol, seven less than in February.

An information circular issued by the national regulatory body, effective Tuesday, updates drugs whose exports have been temporarily suspended, a list that is determined monthly and includes drugs that were disrupted in the previous month and whose impact is considered to be medium or higher. in accordance with the provision on accessibility.

The updated list includes 130 drugs of various categories and active substances, including several drugs for the treatment of diabetes mellitus, urinary incontinence, antibacterial, antipsychotic, intestinal anti-inflammatory, analgesics and antipyretics, antiepileptic and anticonvulsants, as well as vaccines against diphtheria, tetanus and whooping cough, hepatitis A vaccine, live rotavirus vaccine, and hepatitis B vaccine.

Infarmed adds that the ban is intended to ensure supply to the national market after the disruption occurs and applies to all participants in the chain, including manufacturers.

However, it is indicated that this ban applies to drugs included in the list, and not to drugs produced for export.

“Ensuring that citizens have access to the medicines they need is one of the most important aspects of the fundamental right to health care,” warns Infarmed in a note published on its website, according to which “all participants in circular medicine within the framework of providing public service, have their task guarantee uninterrupted and adequate access to medicines.”

Infarmed is part of the European network of points of contact for competent national authorities, the European Medicines Agency (EMA) and the European Commission, which has been used since April 2019 to share information about supply disruptions and problems with the availability of authorized medicines in the European Union.

At Infarmed, drug availability management is provided by the Division of Interagency Projects and Health Systems (USS), which interacts with all stakeholders in the drug chain to jointly discuss each situation in advance and analyze proposals for a solution.

In the context of ongoing work, interaction with the National Commission for Pharmacy and Therapeutics is also important for the development of clinical guidelines.

Author: Portuguese
Source: CM Jornal

Get notified whenever we post something new!

Continue reading